首页> 外文OA文献 >Who and why do researchers opt to publish in post-publication peer review platforms? - findings from a review and survey of F1000 Research
【2h】

Who and why do researchers opt to publish in post-publication peer review platforms? - findings from a review and survey of F1000 Research

机译:谁以及为什么研究人员选择在出版后的同行评审平台中发布? - 从F1000研究审查和调查中的调查结果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background:  Preprint servers and alternative publication platforms enable authors to accelerate the dissemination of their research.  In recent years there has been an exponential increase in the use of such servers and platforms in the biomedical sciences, although little is known about who, why and what experiences researchers have with publishing on such platforms.  In this article we explore one of these alternative publication platforms, F1000 Research, which offers immediate publication followed by post-publication peer review.  Methods: From an unselected cohort of articles published between 13th July 2012 and 30th November 2017 in F1000 Research, we provided a summary of who and what was published on this platform and calculated the percentage of published articles that had been indexed on a bibliographic database (PubMed) following successful post-publication peer review.  We also surveyed corresponding authors to further understand the rationale and experiences of those that have published using this platform.       Results: A total of 1865 articles had been published in the study cohort period, of which 80% (n=1488) had successfully undergone peer review and were indexed on PubMed within a minimum period of six months since first publication. Nearly three-quarters of articles passed the peer review process with their initial submission.  Survey responses were received from 296 corresponding authors. Open access, open peer review and the speed of publication were the three main reasons why authors opted to publish with F1000 Research.     Conclusions: Many who published with F1000 Research had a positive experience and indicated that they would publish again with this same platform in the future.  Nevertheless, there remained some concerns about the peer review process and the quality of the articles that were published.
机译:背景:预印度服务器和替代出版平台使作者能够加速其研究的传播。近年来,一直在使用生物医学这样的服务器和平台的指数增长,但很少有人知道是谁,为什么,什么经验的研究人员有上发布这样的平台。在本文中,我们探讨了这些替代出版平台,F1000研究之一,它提供了立即出版,然后出版后的同行评审。方法:从2012年7月13日至2017年11月30日在F1000研究中发表的未选择的文章队列,我们​​提供了谁以及在该平台上发表的摘要,并计算了在书目数据库上索引的已发表文章的百分比( PUBMED)成功发布后同行评审后。我们还调查了相应的作者,以进一步了解使用此平台发布的理由和经验。结果:在研究队列期间共发表了1865篇文章,其中80%(n = 1488)已成功经历同行评审,并在首次出版以来的最短六个月内被索引。近四分之三的物品通过了初步提交的同行评审过程。从296名相应作者收到调查响应。开放式访问,开放对等审查和出版速度是作者选择与F1000研究发布的三个主要原因。结论:许多与F1000研究发表的人有积极的经验,并表示他们将来会在同一平台上再次发布。尽管如此,对同行评审过程以及公布的文章的质量留下了一些担忧。

著录项

  • 作者

    Jamie Kirkham; David Moher;

  • 作者单位
  • 年度 2018
  • 总页数
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号